4G3Y | Crystal structure of TNF-alpha in complex with Infliximab Fab fragment | date | 2012-07-15 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Liang, S.Y., Dai, J.X., Guo, Y.J., Lou, Z.Y. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.60 | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Structural basis for treating tumor necrosis factor alpha (TNFalpha)-associated diseases with the therapeutic antibody infliximab., Liang S, Dai J, Hou S, Su L, Zhang D, Guo H, Hu S, Wang H, Rao Z, Guo Y, Lou Z, J Biol Chem. 2013 May 10;288(19):13799-807. doi: 10.1074/jbc.M112.433961. Epub, 2013 Mar 15. PMID:23504311 |
Data retrieval |
View 4G3Y in 3D |
Visual 3D analysis of 4G3Y |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4G3Y |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |